I assume Prima Biomed has some kind of clinical proof of concept locked in to justify some of their market cap.
Mate. Once Neuren gets clinical proof of concept in its big ticket programs, we wont be comparing our market cap with PRR... pffft...
We will be comparing market caps with Mesoblast...
exciting old link for new onlookers, page-4
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.65 |
Change
0.430(2.13%) |
Mkt cap ! $2.652B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $21.10 | $20.39 | $5.089M | 245.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1121 | $20.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.68 | 950 | 21 |
View Market Depth
| Last trade - 14.02pm 26/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |